Emanuele Celauro

Emanuele Celauro is a Senior Research Scientist at AstraZeneca since September 2020, with prior experience as a Postdoctoral Researcher at Chalmers tekniska högskola from March 2016 to March 2020. Emanuele's research focuses on Amyotrophic Lateral Sclerosis (ALS), utilizing modern genome editing techniques and therapeutic RNA sequences to investigate the disease's onset and progression in human cell models. Emanuele holds a PhD in Genetics and Molecular Biology from Sapienza Università di Roma, where the doctoral research examined the effects of gene depletion in *Drosophila melanogaster* and *Danio rerio*. Previous roles include IT consultancy and technical support in various companies, highlighting a diverse professional background in both scientific research and technology.